Surrozen SRZN
NASDAQ SRZN
$22.76 +0.22 (+0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Surrozen (SRZN) Share-based Compensation (2020 - 2026)

Surrozen (SRZN) posted quarterly Share-based Compensation of $37.3 million for Q1 2026, up 4372.42% year-over-year from $834000.0 in Q1 2025, and up 3622.55% quarter-over-quarter from $1.0 million in Q4 2025.

Analysis

Surrozen (SRZN) Share-based Compensation (2020 - 2026) Analysis & Trends

Surrozen's Share-based Compensation history runs 7 years deep, the most recent figure standing at $37.3 million for Q1 2026.

  • In Q1 2026, Share-based Compensation rose 4372.42% year-over-year to $37.3 million; the TTM figure through Mar 2026 stood at $37.3 million (up 852.02% YoY), while the FY2025 annual figure was $8.1 million, up 96.89% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $37.3 million, up from $1.0 million in the prior quarter.
  • The five-year high for Share-based Compensation was $37.3 million in Q1 2026, with the low at $834000.0 in Q1 2025.
  • The 5-year median for Share-based Compensation is $1.0 million (2024), against an average of $3.2 million.
  • The sharpest annual moves came in 2023 and 2026: Share-based Compensation fell 24.14% in 2023, then jumped 4372.42% in 2026.
  • Surrozen's Share-based Compensation stood at $1.5 million in 2022, then dropped by 24.14% to $1.2 million in 2023, then decreased by 23.21% to $900000.0 in 2024, then advanced by 11.33% to $1.0 million in 2025, then surged by 3622.55% to $37.3 million in 2026.
  • Business Quant data shows SRZN's Share-based Compensation at $37.3 million in Q1 2026, $1.0 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Surrozen 263.35 Mn 263.35 Mn - 35.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.30 Mn
Mar 31, 2026 2.11 Mn
Dec 31, 2025 1.00 Mn
Sep 30, 2025 1.24 Mn
Jun 30, 2025 1.22 Mn
Mar 31, 2025 923,000.00
Dec 31, 2024 900,000.00
Sep 30, 2024 1.04 Mn
Jun 30, 2024 1.15 Mn
Mar 31, 2024 1.03 Mn
Dec 31, 2023 1.17 Mn
Sep 30, 2023 4.75 Mn
Jun 30, 2023 5.00 Mn
Mar 31, 2023 1.13 Mn
Dec 31, 2022 1.55 Mn
Sep 30, 2022 1.08 Mn
Jun 30, 2022 979,000.00
Mar 31, 2022 916,000.00
Dec 31, 2021 693,000.00
Sep 30, 2021 1.70 Mn